- Home
- BGSF vs ATRA Comparison
BGSF vs ATRA Comparison
Compare BGSF & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGSF
- ATRA
- Stock Information
- Founded
- BGSF 2007
- ATRA 2012
- Country
- BGSF United States
- ATRA United States
- Employees
- BGSF N/A
- ATRA N/A
- Industry
- BGSF Professional Services
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BGSF Consumer Discretionary
- ATRA Health Care
- Exchange
- BGSF Nasdaq
- ATRA Nasdaq
- Market Cap
- BGSF 49.7M
- ATRA 40.1M
- IPO Year
- BGSF N/A
- ATRA 2014
- Fundamental
- Price
- BGSF $4.41
- ATRA $7.80
- Analyst Decision
- BGSF Strong Buy
- ATRA Buy
- Analyst Count
- BGSF 1
- ATRA 5
- Target Price
- BGSF $9.00
- ATRA $17.75
- AVG Volume (30 Days)
- BGSF 16.0K
- ATRA 78.0K
- Earning Date
- BGSF 05-07-2025
- ATRA 05-15-2025
- Dividend Yield
- BGSF N/A
- ATRA N/A
- EPS Growth
- BGSF N/A
- ATRA N/A
- EPS
- BGSF N/A
- ATRA N/A
- Revenue
- BGSF $266,968,000.00
- ATRA $199,732,000.00
- Revenue This Year
- BGSF $4.29
- ATRA N/A
- Revenue Next Year
- BGSF N/A
- ATRA N/A
- P/E Ratio
- BGSF N/A
- ATRA N/A
- Revenue Growth
- BGSF N/A
- ATRA 475.53
- 52 Week Low
- BGSF $2.91
- ATRA $5.01
- 52 Week High
- BGSF $9.22
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- BGSF 62.89
- ATRA 58.85
- Support Level
- BGSF $4.18
- ATRA $6.80
- Resistance Level
- BGSF $4.55
- ATRA $8.10
- Average True Range (ATR)
- BGSF 0.23
- ATRA 0.59
- MACD
- BGSF 0.02
- ATRA 0.07
- Stochastic Oscillator
- BGSF 84.14
- ATRA 82.46
About BGSF BGSF Inc.
BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).